Struewing JP - Search Results

1

Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.

Rutter JL, Bromley CM, Goldstein AM, Elder DE, Holly EA, Guerry D 4th, Hartge P, Struewing JP, Hogg D, Halpern A, Sagebiel RW, Tucker MA. Rutter JL, et al. Among authors: struewing jp. Cancer. 2004 Dec 15;101(12):2809-16. doi: 10.1002/cncr.20669. Cancer. 2004. PMID: 15529312 Free article.

2

A natural history of melanomas and dysplastic nevi: an atlas of lesions in melanoma-prone families.

Tucker MA, Fraser MC, Goldstein AM, Struewing JP, King MA, Crawford JT, Chiazze EA, Zametkin DP, Fontaine LS, Clark WH Jr. Tucker MA, et al. Among authors: struewing jp. Cancer. 2002 Jun 15;94(12):3192-209. doi: 10.1002/cncr.10605. Cancer. 2002. PMID: 12115352 Free article.

3

Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control study.

Rutter JL, Wacholder S, Chetrit A, Lubin F, Menczer J, Ebbers S, Tucker MA, Struewing JP, Hartge P. Rutter JL, et al. Among authors: struewing jp. J Natl Cancer Inst. 2003 Jul 16;95(14):1072-8. doi: 10.1093/jnci/95.14.1072. J Natl Cancer Inst. 2003. PMID: 12865453

4

Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes.

Sigurdson AJ, Hauptmann M, Chatterjee N, Alexander BH, Doody MM, Rutter JL, Struewing JP. Sigurdson AJ, et al. Among authors: struewing jp. BMC Cancer. 2004 Mar 12;4:9. doi: 10.1186/1471-2407-4-9. BMC Cancer. 2004. PMID: 15113441 Free PMC article.

5

Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations.

Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA. Goldstein AM, et al. Among authors: struewing jp. J Natl Cancer Inst. 2000 Jun 21;92(12):1006-10. doi: 10.1093/jnci/92.12.1006. J Natl Cancer Inst. 2000. PMID: 10861313

6

A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.

Goldstein AM, Liu L, Shennan MG, Hogg D, Tucker MA, Struewing JP. Goldstein AM, et al. Among authors: struewing jp. Br J Cancer. 2001 Aug 17;85(4):527-30. doi: 10.1054/bjoc.2001.1944. Br J Cancer. 2001. PMID: 11506491 Free PMC article.

7

Prospective risk of cancer in CDKN2A germline mutation carriers.

Goldstein AM, Struewing JP, Fraser MC, Smith MW, Tucker MA. Goldstein AM, et al. Among authors: struewing jp. J Med Genet. 2004 Jun;41(6):421-4. doi: 10.1136/jmg.2004.019349. J Med Genet. 2004. PMID: 15173226 Free PMC article.

8

The HER2 I655V polymorphism and breast cancer risk in Ashkenazim.

Rutter JL, Chatterjee N, Wacholder S, Struewing J. Rutter JL, et al. Epidemiology. 2003 Nov;14(6):694-700. doi: 10.1097/01.ede.0000083227.74669.7b. Epidemiology. 2003. PMID: 14569185

9

Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.

Hartge P, Chatterjee N, Wacholder S, Brody LC, Tucker MA, Struewing JP. Hartge P, et al. Among authors: struewing jp. Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004. Epidemiology. 2002. PMID: 11964925

10

CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARF.

Rutter JL, Goldstein AM, Dávila MR, Tucker MA, Struewing JP. Rutter JL, et al. Among authors: struewing jp. Oncogene. 2003 Jul 10;22(28):4444-8. doi: 10.1038/sj.onc.1206564. Oncogene. 2003. PMID: 12853981

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters